Antiseptics are antimicrobial substances that are applied to living tissue/skin to reduce the possibility of infection, sepsis, or putrefaction. Antiseptics are generally distinguished from antibiotics by their ability to be transported through the lymphatic system to destroy bacteria within the body, and from disinfectants, which destroy microorganisms found on non-living objects. Some antiseptics are true germicides, capable of destroying microbes (bacteriocidal), whilst others are bacteriostatic and only prevent or inhibit their growth.
Researchers assessed the effectiveness of artemisinin-based antimalarials in the management of COVID-19.
New research examined SARS-CoV-2 and its impact on oral health and suggests that survival against the infection may be partially dependent on such factors.
A new study investigates the presence of SARS-CoV-2 in tears and eye secretions and describes the ocular symptoms in patients with COVID-19.
A recent study, published in the American Society for Microbiology’s journal, mSphere, evaluated the use of many liquid chalk products as antiseptics against the transmission of highly pathogenic human viruses such as influenza A virus (H1N1), SARS-CoV-2, (IAV), and norovirus in a mouse norovirus (MNV) model. The researchers applied chalk before or after virus inoculum and determined the recovery of infectious virus to mimic its use in the gym setting.
A new study describes the identification of new compounds from a library, with inhibitory activity against several coronaviruses. This study shows the utility of this method, besides identifying compounds that not only inhibit viral shedding in SARS-CoV-2 cultures, but have an immunomodulatory effect that may be useful in mitigating the damaging cytokine storm typical of severe or critical COVID-19.
COVID-19 patients are at least three times more likely to experience complications if they also have gum disease, according to research published today in the Journal of Clinical Periodontology, the official publication of the European Federation of Periodontology.
A recent study demonstrated that two commercially available surface disinfectant formulations and one hand disinfection formulation that claim "virucidal activity against enveloped viruses" are effective in inactivating the SARS-CoV-2 virus. Their study has been published on the preprint server bioRxiv.
A team of biophysics from leading Russian research and educational institutions (MSU, RUDN University, and the Federal Research and Clinical Center of the Federal Medical-Biological Agency of Russia) developed a computer model that shows the effect of antiseptics on bacterial membranes.
Certain oral antiseptics and mouthwashes may have the ability to inactivate human coronaviruses, according to a Penn State College of Medicine research study.
Immune reactions caused by vaccination can help protect the organism, or sometimes may aggravate the condition.
Surgeons could dramatically reduce the risk of infection after an operation by simply changing the antiseptic they use.
Cleaning products, alcohol-based sanitizers and other common chemicals are all being used on surfaces to try to kill the virus that causes COVID-19, but knowing how much to use and how long to use it for is unknown, according to Craig Meyers, distinguished professor of microbiology and immunology and obstetrics and gynecology, College of Medicine, Penn State, who is looking at testing these chemicals to find out.
Researchers at Lund University in Sweden have developed a new hydrogel based on the body's natural peptide defense.
A team of scientists from the MISiS National University of Science and Technology with colleagues from the Central European Institute of Technology and other Czech universities have developed a biodegradable material with antibacterial action to use as a dressing on damaged skin.
There are many definitions of hard-to-heal. More conventionally, it's based on underlying etiology of the wound, but in practice it's any wound that has not healed within a timely fashion. This is often due to a lack of coordinated care.
The U.S. Food and Drug Administration today filed a complaint against Innovative BioDefense, Inc. of Lake Forest, California, and Colette Cozean, the company's president and chief executive officer, to prohibit them from selling Zylast topical antiseptics with claims that they are effective against infection by pathogens such as norovirus, rotavirus, flu virus, Methicillin-Resistant Staphylococcus Aureus, and Ebola.
When it comes to the examination room at your health care clinic, you might think that avoiding catching the flu or other more deadly viruses is out of your hands, so to speak.
A new in-vitro study by University of California, Davis, researchers indicates that quaternary ammonium compounds, or "quats," used as antimicrobial agents in common household products inhibit mitochondria, the powerhouses of the cell, as well as estrogenic functions in cells.
Tecnalia's Pharmaceutical Development laboratory conducts the selection of the candidate polymers and topical antiseptics necessary to obtain a stable, safe and effective formula in the form of a transparent bioadjesive gel specific for the treatment of diabetic foot ulcers.
Infections contracted during surgical operations are a serious healthcare problem, leading to death in some cases. Now, a research project at the University of Huddersfield is investigating the use of nanoparticles as a way to disinfect wounds. It could prove to be much more effective than existing techniques because the particles would be tiny enough to enter the skin via hair follicles, ensuring much better penetration of the area affected by surgery.